Extended-Release Melatonin in Patients With Rapid Eye Movement Sleep Behavior Disorder

  • STATUS
    Recruiting
  • End date
    Jun 3, 2023
  • participants needed
    50
  • sponsor
    Mayo Clinic
Updated on 3 June 2022

Summary

The purpose of this research is to compare the efficacy of immediate versus extended-release melatonin as a supplement affecting the sleep cycle in patients with Parkinson disease and Rapid Eye Movement Sleep Behavior Disorder.

Description

Enrolled patients with Parkinson disease and previously diagnosed rapid eye movement sleep behavior disorder, who are being treated at Mayo Clinic in Florida, will be randomized to receive either immediate-release melatonin or extended-release melatonin and then will be crossed over to receive the opposite intervention. The study will consist of two treatment periods of 4 weeks separated by a washout period of 2 weeks.

Details
Condition Rapid Eye Movement Sleep Behavior Disorder, Parkinson Disease
Treatment Immediate Release Melatonin, Extended Release Melatonin
Clinical Study IdentifierNCT05307770
SponsorMayo Clinic
Last Modified on3 June 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

Diagnosed with Parkinson's disease and rapid eye movement sleep behavior disorder
Patient registered to Parkinson's disease database of Mayo Clinic Florida

Exclusion Criteria

Patients who are using other sleep aids or medications (Clonazepam)
Patients who are not willing to undertake 1 week of washout period
Patients who do not sign a consent for research
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note